Moderna Secures 4,206 Sq Ft at London’s Tribeca for UK Headquarters
Moderna has secured 4,206 sq ft of office space at Tribeca in King’s Cross, London, for its new UK commercial headquarters. The US biotechnology company will relocate its UK headquarters to the development, adding another occupier to the growing life sciences and innovation destination.
The agreement was secured by Reef + Partners and BlackRock Real Estate, the organisations behind the Tribeca development. Moderna specialises in mRNA medicines, placing the company within a cluster of businesses and institutions focused on science, research and technology.
Moderna joins King’s Cross innovation campus
Tribeca is an important project for mixed-use life sciences and innovation in King’s Cross. This campus is made up of laboratories, office spaces, innovative workspaces and other commercial activities.
Due to its location, users of the project are within the London Knowledge Quarter - an area highly concentrated in research institutions and the companies that work in technology. The neighborhood that surrounds the development includes such institutions as the Francis Crick Institute and University College London.
The development has been created specifically for those working in scientific research and bioengineering. Moderna's decision to establish its UK commercial headquarters there adds to the range of businesses choosing the campus for their operations.
Commercial leasing activity at Tribeca
The agreement also adds to the leasing activity at the development. Reef + Partners and BlackRock Real Estate have been bringing new occupiers into the campus as its buildings take shape and become available.
Moderna's 4,206 sq ft requirement represents a relatively focused office commitment within a development that combines different types of commercial space. Its arrival further strengthens Tribeca's position as a destination for businesses operating in the life sciences sector.
The latest agreement highlights the role of specialist developments in attracting companies that need access to research facilities, scientific institutions and business networks.
For Tribeca, securing Moderna as an occupier brings another international biotechnology company into its King’s Cross business community.
